NeogenVet BotVax B Vaccine (Clostridium botulinum Type B Toxoid) delivers USDA-approved protection for healthy horses against equine botulism Type B caused by Clostridium botulinum. This serious and potentially fatal neurological disease presents a significant risk to horses, making prevention a critical part of responsible equine health management.
BotVax B stimulates a strong immune response and helps horses develop protective antibodies against Type B botulinum toxin, the most common form of equine botulism in many regions. Veterinarians recommend this vaccine for horses with increased risk due to feeding practices, forage type, or environmental exposure.
When horse owners incorporate NeogenVet BotVax B into a veterinarian-guided vaccination program, they reduce the risk of botulism and support long-term health, safety, and performance. This vaccine plays an essential role in protecting broodmares, foals, performance horses, and pleasure horses alike.
NeogenVet BotVax B meets strict USDA standards for safety, potency, and efficacy. When veterinarians administer the vaccine according to established guidelines, it delivers reliable protection as part of a comprehensive equine preventive care plan.




Reviews
There are no reviews yet.